In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
SciClone receives patent for treatment of hepatitis B
Medicis and BioMarin Reach Settlement
BioMarin and Genzyme to conduct trial on MPS-I treatment
Hi-Tech Pharmacal Launches Authorized Generic of BioMarin Pharmaceutical's Orapred
BioMarin to Obtain Profitable Pediatric Business from Medicis
Aurora Biosciences receives issuance of beta-lactamase patent